Optivise Advisory Services’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$413K Buy
3,993
+7
+0.2% +$625 0.21% 130
2026
Q1
$286K Sell
3,986
-3
-0.1% -$231 0.17% 135
2025
Q4
$317K Sell
3,989
-8
-0.2% -$631 0.18% 133
2025
Q3
$301K Buy
3,997
+51
+1% +$3.5K 0.18% 128
2025
Q2
$272K Sell
3,946
-5
-0.1% -$328 0.14% 150
2025
Q1
$268K Buy
+3,951
New +$236K 0.15% 143
2024
Q4
Sell
-4,112
Closed -$259K 183
2024
Q3
$259K Buy
4,112
+282
+7% +$16.5K 0.14% 136
2024
Q2
$226K Buy
+3,830
New +$240K 0.12% 163

Other funds holding CVS

Optivise Advisory Services's CVS Position: Q2 2026 in Review

Optivise Advisory Services increased its CVS Health (CVS) stake by 0.18% in Q2 2026, buying an estimated $625 and bringing the position to 3,993 shares worth $413K. The position accounts for 0.21% of the portfolio, ranked #130.

Optivise Advisory Services first reported a position in CVS in Q2 2024 and has held it in 8 quarters since. 684 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Optivise Advisory Services held 3,993 shares of CVS Health worth $413K as of Q2 2026.
  • Optivise Advisory Services bought 7 CVS Health shares in Q2 2026, an estimated $625.
  • CVS Health made up 0.21% of Optivise Advisory Services's portfolio in Q2 2026, its #130 holding.
  • Optivise Advisory Services first reported a position in CVS Health in Q2 2024 and has held it in 8 quarters since.
  • 684 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Optivise Advisory Services's 13F filing for Q2 2026, filed 13 Jul 2026.